Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo

Journal of Cellular Biochemistry

Volumn 103, Issue 2, 2008, Pages 663-674

  Jeong, Han Kang ^a   Chae, Young Mi ^a   Park, Kwan Kyu ^a   Kim, Cheorl Ho ^b   Lee, In Seon ^c   Chang, Young Chae ^a  

^a Catholic University of Daegu   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Keimyung University   (South Korea)

Author keywords

Diabetic nephropathy; Extracellular matrix; Mesangial cell; Sp1 decoy oligodeoxynucleotides; Streptozotocin

Indexed keywords

COLLAGEN TYPE 4; CREATININE; FIBRONECTIN; LIPOSOME; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; PLATELET DERIVED GROWTH FACTOR; STREPTOZOCIN; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; MESANGIUM CELL; NONHUMAN; PARAINFLUENZA VIRUS 1; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RAT; RENAL ARTERY; URINARY EXCRETION;

ALBUMINURIA; ANIMALS; BINDING, COMPETITIVE; CELLS, CULTURED; COLLAGEN TYPE IV; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; GENETIC VECTORS; INJECTIONS, INTRA-ARTERIAL; MALE; MESANGIAL CELLS; OLIGODEOXYRIBONUCLEOTIDES; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RENAL ARTERY; SENDAI VIRUS; SP1 TRANSCRIPTION FACTOR; STREPTOZOCIN; TRANSDUCTION, GENETIC;

RATTUS; SENDAI VIRUS;

EID: 38649130217     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21440     Document Type: Article

References (24)

1. Ahn JD, Morishita R, Kaneda Y, Kim HJ, Kim YD, Lee HJ, Lee KU, Park JY, Kim YH, Park KK, Chang YC, Yoon KH, Kwon HS, Park KG, Lee IK. 2004. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo. Gene Ther 11:916-923.
2. Ahn JD, Morishita R, Kaneda Y, Lee SJ, Kwon KY, Choi SY, Lee KU, Park JY, Moon IJ, Park JG, Yoshizumi M, Ouchi Y, Lee IK. 2002. Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo. Circ Res 90:1325-1332.
3. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, Imai E. 1996. Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155.
4. Bielinska A, Shivdasani RA, Zhang LQ, Nabel GJ. 1990. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 250:997-1000.
5. Chae YM, Park KK, Lee IK, Kim JK, Kim CH, Chang YC. 2006. Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction. Gene Ther 13:430-439.
6. Cook T, Gebelein B, Belal M, Mesa K, Urrutia R. 1999. Three conserved transcriptional repressor domains are a defining feature of the TIEG subfamily of Sp1-like zinc finger proteins. J Biol Chem 274:29500-29504.
7. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ. 1993. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952-2962.
8. Gilbert RE, Kelly DJ, McKay T, Chadban S, Hill PA, Cooper ME, Atkins RC, Nikolic-Paterson DJ. 2001. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int 59: 1324-1332.
9. Goldberg HJ, Scholey J, Fantus IG. 2000. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 49:863-871.
10. Heldin CH, Westermark B. 1990. Platelet-derived growth factor: Mechanism of action and possible in vivo function. Cell Regul 1:555-566.
11. Holmgren L, O'Reilly MS, Folkman J. 1995. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153.
12. Irvine SA, Foka P, Rogers SA, Mead JR, Ramji DP. 2005. A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucleic Acids Res 33:1423-1434.
13. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. 1993. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92: 2597-2601.
14. Kang JH, Park KK, Lee IS, Magae J, Ando K, Kim CH, Chang YC. 2006. Proteome Analysis of Responses to Ascochlorin in a Human Osteosarcoma Cell Line by 2-D Gel Electrophoresis and MALDI-TOF MS. J Proteome Res 5:2620-2631.
15. Magae J, Hayasaki J, Matsuda Y, Hotta M, Hosokawa T, Suzuki S, Nagai K, Ando K, Tamura G. 1988. Antitumor and antimetastatic activity of an antibiotic, ascofuranone, and activation of phagocytes. J Antibiot (Tokyo) 41: 959-965.
16. Magae J, Munemura K, Ichikawa C, Osada K, Hanada T, Tsuji RF, Yamashita M, Hino A, Horiuchi T, Uramoto M, et al. 1993. Effects of microbial products on glucose consumption and morphology of macrophages. Biosci Biotechnol Biochem 57:1628-1631.
17. Parameswaran N, Hall CS, Bock BC, Sparks HV, Gallo KA, Spielman WS. 2002. Mixed lineage kinase 3 inhibits phorbol myristoyl acetate-induced DNA synthesis but not osteopontin expression in rat mesangial cells. Mol Cell Biochem 241:37-43.
18. Park KK, Deok Ahn J, Lee IK, Magae J, Heintz NH, Kwak JY, Lee YC, Cho YS, Kim HC, Chae YM, Ho Kim Y, Kim CH, Chang YC. 2003. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP. Biochem Biophys Res Commun 308:689-697.
19. Park YG, Nesterova M, Agrawal S, Cho-Chung YS. 1999. Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide gene-specific inhibition of tumor growth. J Biol Chem 274:1573-1580.
20. Ross R. 1989. Platelet-derived growth factor. Lancet 1: 1179-1182.
21. Shultz PJ, DiCorleto PE, Silver BJ, Abboud HE. 1988. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 255:F674-F684.
22. Steffes MW, Osterby R, Chavers B, Mauer SM. 1989. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081.
23. Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarian M. 1995. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 48:111-117.
24. Waldherr R, Noronha IL, Niemir Z, Kruger C, Stein H, Stumm G. 1993. Expression of cytokines and growth factors in human glomerulonephritides. Pediatr Nephrol 7:471-478.